ArticleActa pharmacologica Sinica2023

Atranorin inhibits NLRP3 inflammasome activation by targeting ASC and protects NLRP3 inflammasome-driven diseases.

Hao-Yu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.